Natural Chalcones for the Management of Obesity Disease
Maria Maisto1, Adua Marzocchi1, Niloufar Keivani1
1Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 59, 80131 Naples, Italy.
Abstract:
In the last decade, the incidence of obesity has increased dramatically worldwide, reaching a dangerous pandemic spread. This condition has serious public health implications as it significantly increases the risk of chronic diseases such as type 2 diabetes, fatty liver, hypertension, heart attack, and stroke. The treatment of obesity is therefore the greatest health challenge of our time. Conventional therapeutic treatment of obesity is based on the use of various synthetic molecules belonging to the class of appetite suppressants, lipase inhibitors, hormones, metabolic regulators, and inhibitors of intestinal peptide receptors. The long-term use of these molecules is generally limited by various side effects and tolerance. For this reason, the search for natural alternatives to treat obesity is a current research goal. This review therefore examined the anti-obesity potential of natural chalcones based on available evidence from in vitro and animal studies. In particular, the results of the main in vitro studies describing the principal molecular therapeutic targets and the mechanism of action of the different chalcones investigated were described. In addition, the results of the most relevant animal studies were reported. Undoubtedly, future clinical studies are urgently needed to confirm and validate the potential of natural chalcones in the clinical prophylaxis of obesity.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cancer Prevention
Some...
Direct-Acting Cholinergic Agonists: Pharmacokinetics


